Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 86.80
-1.50 (-1.70%)
Nov 11, 2026, 4:08 PM HKT
Innovent Biologics Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Innovent Biologics stock has a consensus rating of "Strong Buy" and an average price target of $130.13. The average 1-year stock price forecast is 49.92% higher than the current stock price, while the lowest is $94.87 (+9.30%) and the highest is $157.02 (+80.90%).
Price Target: $130.13 (+49.92%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Innovent Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 22 | 21 | 20 | 21 | 21 | 20 |
| Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 28 | 29 | 30 | 30 | 29 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $128.00 | Buy | Maintains | $128.00 | +47.47% | Nov 3, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $129.54 | Buy | Maintains | $129.54 | +49.24% | Oct 31, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $138.63 | Buy | Maintains | $138.63 | +59.71% | Oct 28, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $135.30 | Buy | Maintains | $135.30 | +55.88% | Oct 19, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $125.00 | Buy | Maintains | $125.00 | +44.01% | Sep 17, 2026 |
Financial Forecast
Revenue This Year
18.62B
from 13.04B
Increased by 42.79%
Revenue Next Year
23.18B
from 18.62B
Increased by 24.47%
EPS This Year
1.42
from 0.99
Increased by 43.08%
EPS Next Year
2.16
from 1.42
Increased by 52.42%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.